Security Snapshot

AMEDISYS INC - Common Stock, par value $0.001 per share (AMED) Institutional Ownership

CUSIP: 023436108

13F Institutional Holders and Ownership History from Q1 2014 to Q4 2025

Latest Period

Q4 2025

Institutions Reporting

1

Shares (Excl. Options)

1

Price

$101.00

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place.

Create free account to save this page Review latest holder period
Type / Class
Equity / Common Stock, par value $0.001 per share
Symbol
AMED
Shares outstanding
32,982,385
Price per share
$101.00
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
1
Total reported value
$101
Share change
-581
Value change
-$57,453
Number of holders
1
Price from insider filings
$101.00
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Quick Takeaways

  • AMED - AMEDISYS INC - Common Stock, par value $0.001 per share is tracked under CUSIP 023436108.
  • 1 institution reported positions in Q4 2025.
  • 1 significant owner is listed from Schedule 13D/13G reporting.

What Changed

  • Holder count moved from 4 to 1 between Q3 2025 and Q4 2025.
  • Reported value moved from $57,554 to $101.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Source Evidence

Source: SEC Form 13F

Latest holder context comes from 1 institution filings for Q4 2025.

Open SEC Evidence

Investment Quick Answers

What is CUSIP 023436108?
CUSIP 023436108 identifies AMED - AMEDISYS INC - Common Stock, par value $0.001 per share in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

Significant Owners of AMEDISYS INC - Common Stock, par value $0.001 per share (AMED) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
GOLDMAN SACHS GROUP INC 0% -108% $19,188 -$178,680,496 190 -100% THE GOLDMAN SACHS GROUP, INC. 30 Sep 2025

As of 31 Dec 2025, 1 institutional investors reported holding 1 shares of AMEDISYS INC - Common Stock, par value $0.001 per share (AMED). This represents 0% of the company’s total 32,982,385 outstanding shares.

Institutional Holders of AMEDISYS INC - Common Stock, par value $0.001 per share (AMED) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 1 $101 -$57,453 $101.00 1
2025 Q3 582 $57,554 -$3,198,236,425 $99.79 4
2025 Q2 32,988,261 $3,245,032,619 +$158,439,809 $98.39 318
2025 Q1 31,712,364 $2,937,637,500 -$44,225,875 $92.63 302
2024 Q4 32,072,548 $2,911,289,403 +$45,469,084 $90.79 289
2024 Q3 31,104,840 $3,001,877,264 +$5,995,463 $96.51 282
2024 Q2 31,067,678 $2,853,693,997 +$79,318,831 $91.80 287
2024 Q1 30,596,920 $2,819,745,626 -$78,638,381 $92.16 280
2023 Q4 31,505,475 $2,994,445,626 +$158,414,857 $95.06 285
2023 Q3 29,904,687 $2,793,414,584 -$4,373,774 $93.40 284
2023 Q2 29,980,075 $2,740,518,682 -$71,288,435 $91.44 297
2023 Q1 31,250,815 $2,298,987,210 +$6,757,528 $73.55 276
2022 Q4 31,107,723 $2,599,215,989 -$51,467,952 $83.54 271
2022 Q3 31,547,667 $3,053,632,701 +$111,680,523 $96.79 268
2022 Q2 29,252,616 $3,079,861,282 -$83,631,487 $105.12 271
2022 Q1 30,205,611 $5,201,601,524 +$176,038,628 $172.29 317
2021 Q4 29,255,269 $4,733,452,345 +$74,262,561 $161.88 314
2021 Q3 28,284,976 $4,217,606,134 -$207,742,696 $149.10 340
2021 Q2 28,923,326 $7,084,910,657 +$78,583,021 $244.93 362
2021 Q1 28,502,858 $7,549,005,908 -$67,770,886 $264.79 382
2020 Q4 29,105,018 $8,536,392,508 +$83,416,142 $293.33 392
2020 Q3 28,914,071 $6,828,800,828 -$191,408,695 $236.43 384
2020 Q2 29,715,664 $5,899,715,526 +$146,681,226 $198.54 343
2020 Q1 29,014,408 $5,322,433,405 +$4,554,348 $183.54 323
2019 Q4 29,002,217 $4,841,499,681 -$100,707,757 $166.92 319
2019 Q3 29,784,935 $3,901,788,451 +$121,585,155 $131.01 278
2019 Q2 29,001,205 $3,515,931,567 +$145,221,977 $121.41 282
2019 Q1 28,204,661 $3,475,093,372 -$140,796,705 $123.26 312
2018 Q4 29,394,527 $3,442,699,144 -$109,087,531 $117.11 295
2018 Q3 30,200,704 $3,772,804,638 -$16,330,529 $124.96 264
2018 Q2 30,476,407 $2,604,785,331 -$172,195,789 $85.46 212
2018 Q1 32,707,278 $1,973,226,792 +$27,394,125 $60.34 192
2017 Q4 33,069,925 $1,743,131,691 +$26,735,181 $52.71 186
2017 Q3 32,496,859 $1,818,025,134 -$52,753,282 $55.96 161
2017 Q2 33,045,448 $2,075,329,751 -$3,908,049 $62.81 167
2017 Q1 33,193,909 $1,695,961,518 +$308,926,227 $51.09 152
2016 Q4 32,510,105 $1,385,955,167 +$33,441,800 $42.63 157
2016 Q3 31,684,214 $1,502,497,074 +$69,062,700 $47.44 152
2016 Q2 31,002,719 $1,564,974,191 +$23,317,389 $50.48 165
2016 Q1 30,512,497 $1,474,889,487 +$25,220,606 $48.34 166
2015 Q4 30,164,535 $1,186,345,410 -$2,783,037 $39.32 164
2015 Q3 30,256,083 $1,148,858,026 +$32,918,319 $37.97 170
2015 Q2 29,365,673 $1,166,694,554 +$44,691,262 $39.73 141
2015 Q1 28,315,891 $758,765,807 -$11,413,659 $26.78 129
2014 Q4 28,726,805 $843,051,239 -$23,201,331 $29.35 136
2014 Q3 30,046,900 $606,059,851 -$7,590,031 $20.17 123
2014 Q2 30,581,280 $512,197,698 +$6,069,964 $16.74 121
2014 Q1 30,281,819 $451,104,208 +$10,905,819 $14.89 118
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .